| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9123229ba9256881a8572fb1ebb148b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9162095dee0e7ebb4644c7f83696a01a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6f8d4365f5987a035304c10ee4dc308 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0019 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-14 |
| filingDate |
2009-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11070d37476f06f547eb75593e315839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80de8a381457ccb0a6a09693382e7f15 |
| publicationDate |
2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9861799-B2 |
| titleOfInvention |
Cerebrospinal fluid shunt having long term anti-occlusion agent delivery |
| abstract |
A shunt for at least partial implantation into a patient that includes an elongated conduit having at least one lumen therethrough and a second lumen concentric about the first lumen along at least part of the first lumen, that includes a proximal end for receipt of bodily fluids for flow through the shunt and a distal end for discharge of the bodily fluids from the shunt, and a long term source of at least one occlusion resistant agent, wherein said at least a portion of the at least one occlusion resistant agent can permeate through at least a portion of the elongated conduit. The invention also includes kits and systems. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439798-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045632-B2 |
| priorityDate |
2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |